Fanucci Marsha 4

What Happened

• Marsha Fanucci, a director of Generate Biomedicines, was granted a derivative award on 2026-02-26 covering 29,561 shares. The Form 4 reports an acquisition price of $0.00, indicating an option/grant rather than a market purchase or sale. No cash changed hands in this reported transaction.

Key Details

• Transaction date: 2026-02-26; Form filed: 2026-03-02 (within the normal 2-business-day Form 4 filing window).
• Instrument: Derivative grant (option) for 29,561 shares; acquisition price reported as $0.00.
• Vesting: Per footnote F1, the shares underlying the option vest in full on February 19, 2027, contingent on continued service.
• Shares owned after transaction: not specified in the supplied filing details.
• Transaction code: A (award/grant).

Context

• This was an equity award (option) not an open-market buy or sale — the award gives the right to acquire shares in the future if vested/exercised. Because it vests on a future date, it does not represent immediate stock ownership or liquidity.